Fouzia Laghrissi-Thode is the founder of DalCor Pharmaceuticals. DalCor Pharmaceuticals has raised $80M in total funding. Latest round: Series D.
Fouzia Laghrissi-Thode is the CEO of DalCor Pharmaceuticals, a company focused on developing precision medicine for cardiovascular disease. DalCor Pharmaceuticals recently closed an $80 million Series D financing round to fund the Dal-GenE-2 confirmatory trial for dalcetrapib.
Full founder directory · Investor directory · Company funding database · Fundraising library